Digital Creating what nature has not from AI and computational molec... Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.
Digital On collaboration, computational chemistry, and cutting-edge ... Dr Olga Nissan, vice president of business development at Evogene discusses collaboration with Google Cloud & generative design of small molecules.
R&D Harnessing the cell's own degradation machinery, with Benedi... Benedict Cross, Chief Technology Officer at PhoreMost, discusses targeted protein degradation.
News Protein misfolding specialist Gain nets $40m from IPO Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with prot
Events Partner Content 3rd Annual Computational Drug Development (CDD) for Biologic... CDD for Biologics | 13-15 November 2018 | Boston, USA
News Gilead claims first FDA nod for a hepatitis D therapy At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.